Medpace Holdings has been growing earnings at an average annual rate of 21.6%, while the Life Sciences industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 19% per year. Medpace Holdings's return on equity is 76.9%, and it has net margins of 17.2%.
Key information
21.61%
Earnings growth rate
25.60%
EPS growth rate
Life Sciences Industry Growth
26.83%
Revenue growth rate
19.01%
Return on equity
76.95%
Net Margin
17.19%
Next Earnings Update
22 Jul 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Medpace Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
BIT:1MEDP Revenue, expenses and earnings (USD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
2,678
460
188
0
31 Dec 25
2,530
451
198
0
30 Sep 25
2,358
433
198
0
30 Jun 25
2,232
418
199
0
31 Mar 25
2,157
416
194
0
31 Dec 24
2,109
404
180
0
30 Sep 24
2,071
366
177
0
30 Jun 24
2,030
340
169
0
31 Mar 24
1,963
312
167
0
31 Dec 23
1,886
283
161
0
30 Sep 23
1,782
273
152
0
30 Jun 23
1,673
268
146
0
31 Mar 23
1,563
257
140
0
31 Dec 22
1,460
245
131
0
30 Sep 22
1,374
227
126
0
30 Jun 22
1,286
209
118
0
31 Mar 22
1,213
199
112
0
31 Dec 21
1,142
181
108
0
30 Sep 21
1,094
182
103
0
30 Jun 21
1,028
175
98
0
31 Mar 21
955
159
93
0
31 Dec 20
926
145
92
0
30 Sep 20
896
124
91
0
30 Jun 20
882
107
97
0
31 Mar 20
891
110
99
0
31 Dec 19
861
100
95
0
30 Sep 19
823
93
95
0
30 Jun 19
786
88
84
0
31 Mar 19
742
78
81
0
31 Dec 18
705
73
76
0
30 Sep 18
612
61
72
0
30 Jun 18
531
52
70
0
31 Mar 18
456
45
64
0
31 Dec 17
386
39
63
0
30 Sep 17
382
28
63
0
30 Jun 17
379
23
63
0
31 Mar 17
377
18
63
0
31 Dec 16
371
13
62
0
30 Sep 16
361
5
65
0
30 Jun 16
348
0
60
0
31 Mar 16
332
-5
57
0
31 Dec 15
320
-9
54
0
Quality Earnings: 1MEDP has high quality earnings.
Growing Profit Margin: 1MEDP's current net profit margins (17.2%) are lower than last year (19.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 1MEDP's earnings have grown significantly by 21.6% per year over the past 5 years.
Accelerating Growth: 1MEDP's earnings growth over the past year (10.6%) is below its 5-year average (21.6% per year).
Earnings vs Industry: 1MEDP earnings growth over the past year (10.6%) exceeded the Life Sciences industry 5.4%.
Return on Equity
High ROE: 1MEDP's Return on Equity (76.9%) is considered outstanding.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/17 04:11
End of Day Share Price
2026/06/17 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medpace Holdings, Inc. is covered by 20 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.